Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Internal Medicine Journal|July 10, 2013
Developing a national database for metastatic colorectal cancer management: perspectives and challengesK Field, H-L Wong, J Shapiro, et al.
Cancer Biomarkers : Section a of Disease Markers|July 11, 2013
Serum concentrations of brain-derived neurotrophic factor (BDNF) are decreased in colorectal cancer patientsG V Brierley, I K Priebe, L Purins, et al.
Alimentary Pharmacology & Therapeutics|May 17, 2014
Randomised clinical trial: L-ornithine-L-aspartate reduces significantly the increase of venous ammonia concentration after TIPSSM Bai, C He, Z Yin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 9, 2015
Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancerJ Tie, I Kinde, Y Wang, et al.
Cancer Treatment and Research Communications|June 17, 2024
Early onset metastatic colorectal cancer in AustraliaA Jalali, S Smith, G Kim, et al.
Current Problems in Cancer|September 27, 2021
Initial experience of TAS-102 chemotherapy in Australian patients with Chemo-refractory metastatic colorectal cancerA Jalali, G Gard, S Banks, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
Real-world characteristics and outcomes of patients with BRAF<sup>V600E</sup>-mutant metastatic colorectal cancer in Australia: the COALA projectN Hitchen, H-L Wong, R Wong, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 2, 2017
Prognostic value of MACC1 and proficient mismatch repair status for recurrence risk prediction in stage II colon cancer patients: the BIOGRID studiesU-P Rohr, P Herrmann, K Ilm, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 9, 2022
ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working GroupJ Pascual, G Attard, F-C Bidard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 29, 2019
Circulating tumor DNA as a potential marker of adjuvant chemotherapy benefit following surgery for localized pancreatic cancerB Lee, L Lipton, J Cohen, et al.
Pageof 7